Home Inhibitor Therapeutics

Inhibitor Therapeutics

In operation
-
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

Inhibitor Therapeutics is a drug development company focused on developing and commercializing innovative therapies based on approved active pharmaceutical ingredients for novel, clinically valuable, and patent-protected indications. Our lead product is itraconazole, used for treating Gorlin syndrome, an orphan disease.
Inhibitor Therapeutics, Inc.
Tampa,Florida,United States of America
less than 15 people
January 01, 1992
stilman@tiberend.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs